INTUITIVE SURGICAL INC Annual Report, Year Ended Dec 31, 2018

Intuitive Surgical Inc. (ISRG) reported strong performance in its 2018 10-K filing, with total revenue reaching $3.7 billion, a 19% increase year-over-year. This growth was primarily driven by a 20% increase in instrument and accessory revenue, fueled by an 18% rise in da Vinci procedures performed globally, and a 21% increase in systems revenue. The company expanded its installed base of da Vinci Surgical Systems to approximately 4,986 units. Despite a slight decrease in gross profit margin to 69.9% due to lower service margins, overall operating income saw a healthy 13% increase. The company also reported a significant increase in cash, cash equivalents, and investments, reaching $4.8 billion, indicating a strong liquidity position. ISRG continues to invest heavily in research and development, signaling a commitment to future innovation and growth in the minimally invasive surgery market. The company's strategy focuses on increasing patient, surgeon, and hospital value by offering advanced robotic-assisted surgical solutions. They are expanding their product portfolio with new systems like the da Vinci SP Surgical System and new instruments such as the SureForm staplers, while also navigating regulatory landscapes and competitive pressures. Key growth drivers include the expansion of da Vinci procedures in general surgery, particularly hernia repair and colorectal procedures, as well as continued strength in urology and gynecology, both domestically and internationally. The company's direct sales model in key markets, coupled with a growing installed base and recurring revenue from instruments, accessories, and services, positions it for sustained growth.